UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________
FORM 8-K
______________
Current Report
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 2, 2024 (January 2, 2024)
______________
MOLINA HEALTHCARE, INC.
(Exact name of registrant as specified in its charter)
|
Delaware
|
001-31719
|
13-4204626
|
|
(State or other jurisdiction of
incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
______________
|
200 Oceangate, Suite 100,
Long Beach, California
90802
|
|
(Address of principal executive offices) (Zip Code)
|
Registrant’s telephone number, including area code: (562) 435-3666
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425
under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12
under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to
Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to
Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
Common Stock, $0.001 Par Value
|
MOH
|
New York Stock Exchange
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or
Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
|
Emerging growth company
|
☐
|
| |
|
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any
new or revised financial accounting standards provided pursuant to Section13(a) of the Exchange Act.
|
☐
|
Item 7.01. Regulation FD Disclosure.
On January 2, 2024, Molina Healthcare, Inc. (the “Company”) announced that its acquisition of Bright Healthcare’s California Medicare
business closed effective as of January 1, 2024. The full text of the Company’s press release issued in connection with the announcement is included as Exhibit 99.1 to this report.
Note: The information in this Form 8-K and Exhibit 99.1 attached hereto shall not be deemed to be “filed” for purposes of Section 18
of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the
Exchange Act, except as expressly set forth by specific reference in such a filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits:
|
Exhibit No.
|
Description
|
|
|
|
|
104
|
Cover Page information from Molina Healthcare, Inc.’s Current Report on Form 8-K filed on January 2, 2024 formatted in iXBRL (Inline Extensible
Business Reporting Language)
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its
behalf by the undersigned hereunto duly authorized.
| |
|
MOLINA HEALTHCARE, INC.
|
| |
|
|
|
Date:
|
January 2, 2024
|
By:
|
/s/ Jeff D. Barlow
|
| |
|
|
Jeff D. Barlow
|
| |
|
|
Chief Legal Officer and Secretary
|